With a compound yearly growth rate of 17.3% (Euromonitor figures), the market size of private label cosmetics is expected to surpass 37 billion US dollars by 2025. For new companies using this strategy, starting R&D expenses can be cut by 62%. Using the Private Label solution, a North American skincare company revealed at the 2024 Sephoran Supply Chain Summit that it had shortened the product development cycle from 18 months to 6.2 weeks, cut the first batch of secondary production to 5,000 units, and raised the inventory turnover rate to 5.8 times yearly (the average of 2.3 times in the conventional model). British skincare company Bare Biology is a classic example. The gross profit margin rose to 75% in the first year following the development of its own approach to contract manufacturing, 37.5 percentage points more than that of self-production.
The main advantage is the major decrease in technical obstacles. Conventional Cosmetics companies’ average yearly spending on formula research and development makes up 23% of their income, whereas private label cosmetics providers can share 98% of their pre-certified formula libraries. The Rheinland certification report reveals that, based on this model, a particular South Korean facial mask brand successfully skipped over 2 million US dollars in equipment investment, therefore lowering the range of precise control error of active ingredient concentration to 1.5% (industry standard 5%), and the return rate of the first batch of products was just 2.3%.
Resilience of the supply chain is now the secret to rivalry. The 2024 Global Beauty Supply Chain White Paper estimates that 79% of companies are at risk of cost runaway as raw material prices change. Big Private Label companies have cut the purchase price of hyaluronic acid by 21% below the market through centralized buying. Cosmetica Laboratories of France offers a common example of the full-chain solution for 200 brands: The raw material traceability blockchain system has reduced the replenishment cycle of best-selling goods to 7 days (the industry average is 28 days) and raised the on-time delivery rate to 99.4%. The typhoon disaster in 2022 interfered with the supply of alginic acid, therefore within 48 hours its alternative solution was started to assist collaborating companies prevent losses of more than 1.8 million US dollars.
Greater strategic worth comes from the risk control dimension. According to FDA statistics, recalls brought on by non-compliant formulas cost companies on average 1.3 million US dollars in 2023. Professional Private Label service providers’ compliance database covers 89 international regulations. With a 4-hour early warning response time, the cost of adjusting to new rules is reduced by 68%. While the average time for non-cooperating brands was 152 days, 90% of the brands that followed this model finished formula adjustments within 30 days. A Bain & Company report shows that for companies that successfully implement a private label strategy, the failure rate of new product launches has decreased from 34% to 12%, and the customer lifetime value has grown by 5.8 times.